PABREKO
"PABREKO" is a word mark owned by Fore US Bio Inc., filed at the USPTO on August 6, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since August 6, 2026
- Filed
- August 6, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50035402
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns PABREKO
The owner and representative on file with the office.
Owner
Fore US Bio Inc.
Philadelphia, United States
Representative
Neha Bhalani
Chiesa Shahinian & Giantomasi PC
What the mark covers
The products and services PABREKO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of cancer and oncological disorders, namely, orally administered BRAF inhibitor therapies
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About PABREKO
Who owns the trademark "PABREKO"?
The USPTO trademark "PABREKO" (application 50035402) is owned by Fore US Bio Inc.
What is the status of "PABREKO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull PABREKO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019fdc53-6147-74ff-9978-96e2a59d3a60
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019fdc53-6147-74ff-9978-96e2a59d3a60",
"object": "trademark",
"mark_text": "PABREKO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50035402",
"filing_date": "2026-08-06",
"nice_classes": [
5
],
"owners": [
{
"name": "Fore US Bio Inc.",
"entity_id": null
}
]
}